Absorption of antisense oligonucleotides in rat intestine: Effect of chemistry and length

被引:44
作者
Khatsenko, O
Morgan, R
Truong, L
York-Defalco, C
Sasmor, H
Conklin, B
Geary, RS
机构
[1] ISIS Pharmaceut, Dept Toxicol & Pharmacokinet, Carlsbad, CA 92008 USA
[2] ISIS Pharmaceut, Dept Pharmacol, Carlsbad, CA 92008 USA
[3] ISIS Pharmaceut, Dept Med Chem, Carlsbad, CA 92008 USA
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 2000年 / 10卷 / 01期
关键词
D O I
10.1089/oli.1.2000.10.35
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An in situ single-pass perfusion model was used to assess the effect of chemical modification and length on permeability and absorption of various oligonucleotides in rat intestine. Phosphorothioate oligodeoxynucleotides (PS-ODN) were compared with oligoribonucleotides with 2'-methoxyethyl (MOE) or 2'-O-methyl (OMe) modifications. A 25-mer PS-OMe-modified oligonucleotide showed relatively poor permeability in this model, as did unmodified 20-mer PS-ODN (permeability coefficient [P-eff] = 2-8 x 10(-6)cm/sec). Modifying some or all of the oligonucleotides with 2'-MOE groups on deoxyribose and 5'-methylation of the cytosines substantially increased intestinal permeability of oligonucleotides, Both partially and fully modified PS-MOE oligonucleotides showed a 2-4-fold increase in permeability as compared with unmodified PS-ODN, The presence of a phosphodiester backbone in MOE-modified compounds led to further increases in intestinal permeability, PS-MOE composed of 6, 8, 10, 12, 14, 16, 18, 20, and 22 nucleotides were also examined, It was found that the permeability of these oligonucleotides increased linearly with decreasing length.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 35 条
[1]  
Agrawal S, 1998, HANDB EXP PHARM, V131, P525
[2]   Perspectives in antisense therapeutics [J].
Agrawal, S ;
Iyer, RP .
PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) :151-160
[3]   ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J].
AGRAWAL, S ;
ZHANG, XS ;
LU, ZH ;
ZHAO, H ;
TAMBURIN, JM ;
YAN, YM ;
CAI, HY ;
DIASIO, RB ;
HABUS, I ;
JIANG, ZW ;
IYER, RP ;
YU, D ;
ZHANG, RW .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) :571-576
[4]   EFFICIENT SYNTHESIS OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDE PHOSPHOROTHIOATES [J].
ANDRADE, M ;
SCOZZARI, A ;
COLE, DL ;
RAVIKUMAR, VT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (16) :2017-2022
[5]   Effects of size and sequence on the iontophoretic delivery of oligonucleotides [J].
Brand, RM ;
Wahl, A ;
Iversen, PL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (01) :49-52
[6]  
Crooke ST, 1996, J PHARMACOL EXP THER, V277, P923
[7]   CHARACTERIZATION OF FULLY 2'-MODIFIED OLIGORIBONUCLEOTIDE HETERODUPLEX AND HOMODUPLEX HYBRIDIZATION AND NUCLEASE SENSITIVITY [J].
CUMMINS, LL ;
OWENS, SR ;
RISEN, LM ;
LESNIK, EA ;
FREIER, SM ;
MCGEE, D ;
GUINOSSO, CJ ;
COOK, PD .
NUCLEIC ACIDS RESEARCH, 1995, 23 (11) :2019-2024
[8]   Identification and characterization of second-generation antisense oligonucleotides [J].
Dean, NM ;
Griffey, RH .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (03) :229-233
[9]   DRUG ABSORPTION .I. AN IN SITU RAT GUT TECHNIQUE YIELDING REALISTIC ABSORPTION RATES [J].
DOLUISIO, JT ;
BILLUPS, NF ;
DITTERT, LW ;
SUGITA, ET ;
SWINTOSKY, JV .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (10) :1196-+
[10]   Antisense comes of age [J].
Flanagan, WM .
CANCER AND METASTASIS REVIEWS, 1998, 17 (02) :169-176